Although no difference in total eosinophil count was observed, active eosinophils, determined through CD69 expression, were enriched in the fibrotic deeper layers when compared with those in the unaffected deeper layers of patients with CD and non-IBD controls (P = 0.0008 and P = 0.02) (Figure 3). This evidence concerns the gene CD69 and inflammatory bowel disease.